HPV Drug Gardasil Vaccine Gets FDA Approval for Use in Boys
Links shared publicly online about this topic
FDA Approves Gardasil for Use in Boys and Young Men
drugs.com — “Gardasil (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) is used in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. Includes Gardasil side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 11:21 pm By:
FDA Approves Gardasil for Use in Boys and Young Men - http://bit.ly/22tTYH
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys
fda.gov — “The U.S. Food and Drug Administration today approved use of the vaccine Gardasil for the prevention of genital warts (condyloma acuminata) due to human papillomavirus (HPV) types 6 and 11 in boys and men, ages 9 through 26.” View full resource at fda.gov
Most Recently Shared on October 16, 2009 at 9:35 pm By:
Gannett Healthcare Health News
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys: http://bit.ly/1dyyaf
FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys
medicalnewstoday.com — “The U.S. Food and Drug Administration approved use of the vaccine Gardasil for the prevention of genital warts (condyloma acuminata) due to human papillomavirus (HPV) types 6 and 11 in boys and me” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2009 at 1:43 pm By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys: The U.S. Food and Drug Admini.. http://bit.ly/YSRaN
Observations: Is an HPV vaccine for boys cost-effective?
scientificamerican.com — “An advisory panel for the U.S. Food and Drug Administration (FDA) recently approved the use of Gardasil, a vaccine for the human papillomavirus (HPV), for use in males. A new study , published yesterday in the British Medical Journal , found, howeve” View full resource at scientificamerican.com
Most Recently Shared on October 9, 2009 at 9:11 pm By:
Scientific American Health Magazine
Is an HPV vaccine for boys cost effective? : An advisory panel for the U.S. Food and Drug Administration (FDA) .. http://bit.ly/2Twm0y
UPDATE 1-US OKs Merck shot to prevent male genital warts | Reuters
reuters.com — “* Gardasil cleared for males aged 9 to 26 * Shot already sold for women to fight cervical cancer * Merck shares down 5 cents LOS ANGELES, Oct 16 (Reuters) - Merck & Co won U.S. approval” View full resource at reuters.com
Most Recently Shared on October 17, 2009 at 12:45 am By:
RT: @hrana News: FDA approves Gardasil (HPV vaccine) for use in male genital wart prevention http://bit.ly/tQDyy
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on September 10, 2009 at 1:49 pm By:
eyeonfda Pharma and Health Lawyer
FDA AdComm Recommends Approval for Use of GARDASIL® in Boys and Men http://bit.ly/11VkEl
The Latest on Cervical Cancer Vaccines | Lifescript.com
lifescript.com — “The Food and Drug Administration (FDA) has now approved Merck's Gardasil human papilloma virus (HPV) vaccine for use in boys and men ages 9 to 26. The hope is that immunization of boys and men will help reduce the incidence of HPV transmission to women, thereby reducing the overall occurrence of cervical cancer.” View full resource at lifescript.com
Most Recently Shared on November 5, 2009 at 6:53 pm By:
Our chief medical officer, Dr. Edward Geehr, shares the latest on cervical cancer vaccines: http://bit.ly/u0jyE
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Gannett Healthcare
Nursing Spectrum, NurseWeek and www.Nurse.com
-
MNT Pediatrics News
The latest pediatrics / children's health news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
